Biotest AG
Privately held: no public share price
Assets
(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
0Diseases
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | Hepatitis B virus (HBV)Protein / enzyme therapeutic | Indication not yet linked |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.